Core Scientific purchase doesn’t add any profits to CoreWeave, says D.A. Davidson’s Gil LuriaJuly 8, 2025
Core Scientific purchase doesn’t add any profits to CoreWeave, says D.A. Davidson’s Gil LuriaJuly 8, 2025
Generative AI is overhyped in short-term and underhyped in long-term, says Wired’s Lauren GoodeJuly 8, 2025
Share Facebook Twitter LinkedIn Pinterest Email Greenlight Capital’s David Einhorn gave a new investment idea on Wednesday at the Sohn Investment Conference in New York: Lanxess, a German chemical company.
